The estimated Net Worth of Global Performance Llc Viki... is at least $745 Million dollars as of 27 June 2019. Global Viki owns over 4,705,900 units of BridgeBio Pharma Inc stock worth over $745,121,538 and over the last 5 years Global sold BBIO stock worth over $0.
Global has made over 1 trades of the BridgeBio Pharma Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Global bought 4,705,900 units of BBIO stock worth $80,000,300 on 27 June 2019.
The largest trade Global's ever made was buying 4,705,900 units of BridgeBio Pharma Inc stock on 27 June 2019 worth over $80,000,300. On average, Global trades about 4,705,900 units every 0 days since 2019. As of 27 June 2019 Global still owns at least 26,620,991 units of BridgeBio Pharma Inc stock.
You can see the complete history of Global Viki stock trades at the bottom of the page.
Over the last 5 years, insiders at BridgeBio Pharma Inc have traded over $409,396,563 worth of BridgeBio Pharma Inc stock and bought 12,280,644 units worth $209,241,115 . The most active insiders traders include Global Investors Lp Viking ..., Andrew Lo und Genetic Disorder L.P.Kkr Ge.... On average, BridgeBio Pharma Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,173,197. The most recent stock trade was executed by Neil Kumar on 16 August 2024, trading 55,537 units of BBIO stock currently worth $1,554,481.
we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.
BridgeBio Pharma Inc executives and other stock owners filed with the SEC include: